Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001169232-07-003555
Filing Date
2007-08-30
Accepted
2007-08-29 21:56:28
Documents
6
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT d72645_10k.htm 10-K 3438051
2 GRAPHIC linechart.jpg GRAPHIC 33146
3 SUBSIDIARIES OF THE REGISTRANT d72645_ex21-1.htm EX-21.1 670
4 RULE 13A-14(A)/15D-14(A) CERTIFICATIONS d72645_ex31-1.htm EX-31.1 9259
5 RULE 13A-14(A)/15D-14(A) CERTIFICATIONS d72645_ex31-2.htm EX-31.2 9268
6 SECTION 1350 CERTIFICATIONS d72645_ex32-1.htm EX-32.1 7511
  Complete submission text file 0001169232-07-003555.txt   3511974
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 6506241000
VAXGEN INC (Filer) CIK: 0001036968 (see all company filings)

EIN.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26483 | Film No.: 071089048
SIC: 2834 Pharmaceutical Preparations